STEAP3 and colorectal carcinoma: These clinical data support our preclinical findings and suggest that the upregulation of the lncRNA STEAP3-AS1 occurs in the setting of liver metastasis in patients with CRC, and this upregulation may be consistent with chromatin remodelling disorders in CRC (Fig. 7D).